Long noncoding RNAs-related diseases, cancers, and drugs

ScientificWorldJournal. 2013 Jun 6:2013:943539. doi: 10.1155/2013/943539. Print 2013.

Abstract

Long noncoding RNA (lncRNA) function is described in terms of related gene expressions, diseases, and cancers as well as their polymorphisms. Potential modulators of lncRNA function, including clinical drugs, natural products, and derivatives, are discussed, and bioinformatic resources are summarized. The improving knowledge of the lncRNA regulatory network has implications not only in gene expression, diseases, and cancers, but also in the development of lncRNA-based pharmacology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Drug Design*
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics*
  • RNA, Long Noncoding / genetics*

Substances

  • Antineoplastic Agents
  • RNA, Long Noncoding